triple glp-1/gip/glucagon receptor agonist glp 1 gip From Obesity to Metabolic Health: Why Retatrutide Is a Game-Changer Discovery of a potent and

Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility

Additionally, incretin therapies can have overbearing negative side effects including hypoglycaemia (often in combination with other glucose-lowering treatments), nausea, vomiting, gastrointestinal upset (including diarrhoea) and injection site reactions that contribute to therapy discontinuation (Trujillo et al., 2021)

Ann Family Med 10(1):1522 Rubin RR (2005) Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus

Phentermine is a sympathomimetic amine stimulant, not a GLP-1 receptor agonist

118,119 Delayed post-meal gallbladder emptying in diabetes is referred to as diabetic cholecystoparesis